Vimarsana
Biggest News Aggregation in the World

Page 11 - Acceleron Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acceleron Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acceleron Pharma Today - Breaking & Trending Today

BMS Cancer Drug's New FDA Nod Puts It on Path to Reach Blockbuster Status - Vimarsana News

BMS Cancer Drug's New FDA Nod Puts It on Path to Reach Blockbuster Status

Bristol Myers Squibb drug Reblozyl is now approved as a first-line therapy for anemia caused by myelodysplastic syndromes, a group of blood cancers. It’s the third indication for the drug, which analysts project could top $4 billion in peak sales.

Beta Blockers Global Market Report 2023 - Vimarsana News

Beta Blockers Global Market Report 2023

Major players in the beta blockers market are Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca PLC, Johnson and Johnson, Eli Lilly and Company,...

Aurinia Appoints Two New Board Directors with Deep Experience in BioPharma Leadership, Commercial Strategy, Mergers and Acquisitions and Advancing Therapeutic Pipelines - Vimarsana News

Aurinia Appoints Two New Board Directors with Deep Experience in BioPharma Leadership, Commercial Strategy, Mergers and Acquisitions and Advancing Therapeutic Pipelines

Dr. Karen Smith and Jeffrey A. Bailey joined Aurinia’s Board of Directors August 18, 2023 Dr. Daniel G. Billen appointed Chair of the Board of Directors ...

Aurinia Appoints Two New Board Directors with Deep Experience in BioPharma Leadership, Commercial St - Vimarsana News

Aurinia Appoints Two New Board Directors with Deep Experience in BioPharma Leadership, Commercial St

Dr. Karen Smith and Jeffrey A. Bailey joined Aurinia’s Board of Directors August 18, 2023Dr. Daniel G. Billen appointed Chair of the Board of DirectorsEDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”) today announced that its Board of Directors has appointed...

After the Moderna COVID-19 vaccine, Flagship a new hit - Vimarsana News

After the Moderna COVID-19 vaccine, Flagship a new hit

The Moderna COVID-19 vaccine was the ultimate home run for this biotech venture firm. It’s a tough act to follow.